We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Double Blind Placebo Control Study to Assess the Safety,Tolerability and Efficacy of Copaxone in Crohn's Disease (Cop1CD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00731172
Recruitment Status : Unknown
Verified March 2009 by Tel-Aviv Sourasky Medical Center.
Recruitment status was:  Recruiting
First Posted : August 8, 2008
Last Update Posted : March 3, 2009
Sponsor:
Collaborators:
Information provided by:

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : July 2010
  Estimated Study Completion Date : July 2011